On Saturday, I ran my third marathon in just under six weeks – without having done any training between the races, mind you. Let’s call them recovery breaks, although one of those breaks also involved ten days of pain in my left knee.
A reckless undertaking, some might say. And I can’t really argue with that. But there was, after all, some method to the madness. The five marathons I had planned for 2026 needed to be ticked off the list. And they were – at the very last minute. I won’t be running another single metre this year.
The Bjergbakke Marathon in Ringsted was a cannonball-style marathon consisting of six laps of just over seven kilometres each. The course started at a private residence and followed streets and roads with asphalt and paved surfaces. The weather treated us to moderate rain for half the race, accompanied by a brisk wind. The event was well organised, with a well-stocked refreshment station at the start and finish area.
Next Wednesday, I will undergo treatment with Arthrosamid. It is an injectable hydrogel consisting of 97% water and 3% polyacrylamide. The gel is injected directly into the joint cavity of my left knee, where it integrates into the tissue of the joint lining, known as the synovial membrane. This helps make the tissue more flexible, thereby relieving the pain caused by osteoarthritis.
Following the treatment, I will have to take a break from running for three to five months. I then hope to make my comeback with a marathon in Denmark in the spring, before the year’s big event: The Great Wall Marathon on 15 May.
If the treatment works as intended, as I naturally hope it will, the pain-relieving effect may last for several years – perhaps even five years or longer. There are, however, no guarantees.
If all goes according to plan, I can hopefully look forward to continuing my marathon-running adventures well into my seventies.



